Takeda is sharpening its oncology focus amid an R&D revamp. Sun Pharma will acquire Checkpoint Therapeutics and an ...

Treatments for autoimmune diseases and those in orphan markets are on the up and up, as are drugmakers’ first launches, ...

Two years after first announcing the partnership, Boehringer Ingelheim and software firm Veeva Systems have launched ...

Sartorius invests in new production line in Bengaluru to meet global demands, doubling capacity for chromatography systems.

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug ...

Finnish drugmaker Orion Corporation has announced that it is establishing a new research and development (R&D) center in Cambridge, UK, during 2025 to accelerate its global growth strategy and the ...

Discover how different countries allocate R&D investments across industries and the impact on economic growth and innovation.

The Department of Pharmaceuticals has invited expressions of interest for project funding under the PRIP scheme, aiming to transform India into a global R&D hub in the Pharma MedTech sector.

Our Bureau, New Delhi Monday, March 10, 2025, 17:10 Hrs [IST] The Department of Pharmaceuticals (DoP) has released the Expre ...

Palvelussamme on juuri nyt häiriö, yritäthän myöhemmin uudelleen. Pahoittelemme aiheutunutta haittaa.

Selected financial information (as of December 31, 2024/Consolidated financial statements under IFRS) ...

BullFrog AI plans to introduce what it considers a game-changing approach that could shorten timelines, reduce costs, and ...